Research Grant: Page 2

VolitionRx prices $6M public offering
By LabPulse.com staff writers
The company said that gross proceeds to Volition from the offering are expected to be $6 million. Volition also granted the underwriter a 30-day option to purchase up to an additional 450,000 shares of its common stock at the public offering price. The offering is expected to close on or about August 2.
July 28, 2022
2019 04 26 21 48 5250 Money Hundred Bills 400
AACR announces 2022 cancer research award recipients
By LabPulse.com staff writers
The award recognizes female researchers who have made pioneering contributions to the understanding and treatment of breast and gynecological cancer. This year's awardees include:
April 3, 2022
2019 09 20 23 44 6333 Trophy Award 400
Foundation Medicine secures FDA 'breakthrough' designation
By LabPulse.com staff writers
The FDA granted the designation for use of the assay in detecting molecular residual disease (MRD) in early-stage cancer after curative therapy. These test results can then help to guide further treatment decisions in these patients, according to the vendor.
February 14, 2022
2019 10 09 17 32 0093 Dna Cancer Cell 400
SLAS 2022: 6 tips for scientists looking to start companies
By Leah Sherwood
1. Find the right team
February 8, 2022
2022 02 09 00 27 2956 Business Lab Startup Team 400
Fla. university awarded $1.3M from NIH for HIV test
By LabPulse.com staff writers
With the grant, FAU researchers hope to develop an affordable, disposable self-testing HIV-1 chip that can selectively detect HIV from whole blood samples. The researchers are aiming for an automated test that requires no refrigeration and can produce results within 40 minutes. They also said it will be sensitive enough to detect HIV during acute infection, treatment, and viral rebound, according to a press release issued by the university.
January 17, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Siemens gets FDA nod for ELF test for liver fibrosis
By LabPulse.com staff writers
ELF is a noninvasive blood test intended for use with the company's Advia Centaur XP immunoassay system. The test provides a numeric score that is automatically generated via an algorithm and is used to assess the likelihood of progressing to cirrhosis and liver-related clinical events in patients with severe or advanced fibrosis (F3 or F4) due to nonalcoholic steatohepatitis (NASH).
August 23, 2021
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Researchers get $3.3M to study AI in oral cancer
By LabPulse.com staff writers
The U.S. National Cancer Institute awarded the five-year grant to a group led by Anant Madabhushi, PhD, the Donnell Institute Professor of Biomedical Engineering at CWRU and head of the Center for Computational Imaging and Personalized Diagnostics, and Dr. James Lewis Jr., a pathology, microbiology, and immunology professor at Vanderbilt University Medical Center.
January 5, 2021
2020 03 24 20 53 4672 Dollar Sign Golden 400
Liver cancer diagnostic test offers promise of early detection
By LabPulse.com staff writers
The platform is called EV Click Chips, and the hope is that it will enable more effective purification of extracellular vesicles in blood from people with hepatocellular carcinoma. Researchers from the University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center have received a $2.97 million grant from the U.S. National Cancer Institute (NCI) to develop the technology further.
August 4, 2020
2020 01 22 00 12 9591 Liver Cancer 400
Blood biomarkers show risk for preeclampsia in pregnant women
By Emily Hayes
The proof-of-concept study looked at the levels and ratio of the proteins FK506-binding protein like (FKBPL) and cluster of differentiation 44 (CD44) in plasma of pregnant women and matched normal controls at the Royal Jubilee Maternity Hospital in Belfast, U.K., and how they associated with risk for preeclampsia.
July 7, 2020
2020 07 07 21 16 8808 Pregnant Women Touching Belly 400
Roche IL-6 test cleared, identifies high-risk COVID-19 patients
By LabPulse.com staff writers
The emergency use authorization was granted on June 2 and Roche said that it is available for use on its cobas e analyzers, which are widely available globally. The test is available in countries that accept the CE Mark in addition to the U.S. The cobas analyzers offer throughput of 300 tests per hour and deliver results in approximately 18 minutes, according to the company.
June 3, 2020
2019 11 19 19 30 0103 T Cell 400
Neurofilament light blood test shows concussion damage in study of veterans
By Emily Hayes
Sponsored by grant funding from the U.S. Department of Defense (DOD) Chronic Effects of Neurotrauma Consortium (CENC), the study evaluated levels of the protein NfL in blood tests and how they correlated with concussion in 195 military veterans. Researchers found higher levels in veterans with a history of three or more concussions compared to those who had not had mTBI. In addition, high NfL was associated with more severe symptoms such as post-traumatic stress disorder (PTSD) and depression.
May 27, 2020
2020 05 27 22 53 3904 Army Outstanding Volunteer Medal 400
Fluxergy invests $30M to produce more point-of-care SARS-CoV-2 tests
By LabPulse.com staff writers
The Fluxergy Analyzer test system, which uses polymerase chain reaction (PCR) and microfluidics technology, identified the SARS-CoV-2 virus in less than one hour during bench lab validation studies conducted by the company and in an analysis of patient samples conducted by scientists at the University of California, San Diego (UCSD).
May 12, 2020
2020 05 13 22 44 2311 Fluxergy Beta Product 400
Previous Page
Page 2 of 4
Next Page